Dalili, Michael N.
45  Ergebnisse:
Personensuche X
?
 
?
8

Who is accessing community lateral flow device testing and ..:

Dalili, Michael N ; Long, Jo ; Wadley, Emma...
Dalili , M N , Long , J , Wadley , E , Sloan , J , Cross , A , Thomas , K H & Morgan , G S 2022 , ' Who is accessing community lateral flow device testing and why : Characteristics and motivations of individuals participating in COVID-19 community testing in two English local authority areas ' , BMC Public Health , vol. 22 , no. 1 , 588 , pp. 588 . https://doi.org/10.1186/s12889-022-12986-4.  , 2022
 
?
9

Comparative clinical effectiveness and safety of tobacco ce..:

Thomas, Kyla H ; Dalili, Michael N ; López-López, José A...
Thomas , K H , Dalili , M N , López-López , J A , Keeney , E , Phillippo , D M , Munafò , M R , Stevenson , M , Caldwell , D M & Welton , N J 2022 , ' Comparative clinical effectiveness and safety of tobacco cessation pharmacotherapies and electronic cigarettes : a systematic review and network meta-analysis of randomized controlled trials ' , Addiction , vol. 117 , no. 4 , pp. 861-876 . https://doi.org/10.1111/add.15675.  , 2022
 
?
10

Smoking cessation medicines and e-cigarettes: a systematic ..:

Thomas, Kyla H ; Dalili, Michael N ; Lopez-Lopez, Jose A...
Thomas , K H , Dalili , M N , Lopez-Lopez , J A , Keeney , E , Phillippo , D M , Munafo , M R , Stevenson , M , Caldwell , D M & Welton , N J 2021 , ' Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis ' , Health Technology Assessment , vol. 25 , no. 59 , pp. 1-224 . https://doi.org/10.3310/hta25590.  , 2021
 
?
11

Local authority research systems: a qualitative study to in..:

Dalili, Michael N ; Blackmore, Sara ; Thomas, Kyla H
Dalili , M N , Blackmore , S & Thomas , K H 2021 , Local authority research systems: a qualitative study to inform the development of a South Gloucestershire Council-wide research system . in The Lancet . vol. 398 , Lancet Publishing Group . https://doi.org/10.1016/S0140-6736(21)02580-0.  , 2021
 
?
 
?
14

A cost-effectiveness analysis of smoking cessation interven..:

Keeney, Edna ; Welton, Nicky J ; Stevenson, Matt...
Keeney , E , Welton , N J , Stevenson , M , Dalili , M N , López-López , J A , Caldwell , D M , Phillippo , D M , Munafò , M R & Thomas , K H 2021 , ' A cost-effectiveness analysis of smoking cessation interventions in the UK accounting for major neuropsychiatric adverse events ' , Value in Health , vol. 24 , no. 6 , pp. 780-788 . https://doi.org/10.1016/j.jval.2020.12.012 , https://doi.org/10.1016/j.jval.2020.12.012.  , 2021
 
?
15

How do smoking cessation medicines compare with respect to ..:

Thomas, Kyla H ; Caldwell, Deborah ; Dalili, Michael N...
Thomas , K H , Caldwell , D , Dalili , M N , Gunnell , D , Munafò , M R , Stevenson , M & Welton , N J 2017 , ' How do smoking cessation medicines compare with respect to their neuropsychiatric safety? A protocol for a systematic review, network meta-analysis and cost-effectiveness analysis ' , BMJ Open , vol. 7 , no. 6 , e015414 . https://doi.org/10.1136/bmjopen-2016-015414.  , 2017
 
1-15